Skyrizi 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F02W4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,836
Award facts
- Contract value 100% obligated
- $25,836.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,836.19 to AmerSourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml syringes. The award, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, represents a firm fixed-price procurement with no set-aside designation, indicating the contract was competitively awarded. SKYRIZI (risankizumab) is a biologic immunosuppressant used to treat inflammatory conditions, and this delivery order falls under the company's broader pharmaceutical supply obligations to federal military healthcare systems.
This delivery order is executed under AmerSourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at up to $999,999,999.00 through December 2026), which serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally. AmerSourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and regularly fulfills federal procurement requirements for specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F02W4?
SPE2DR26F02W4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F02W4 worth?
The government has obligated $25,836 on SPE2DR26F02W4.
Is contract SPE2DR26F02W4 an order under another contract?
Yes. SPE2DR26F02W4 is a delivery order under SPE2DR25D2200, an indefinite delivery contract.
Was contract SPE2DR26F02W4 competed?
The extent of competition for SPE2DR26F02W4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award